Skip to main content

Advertisement

Log in

In-stent fractional flow reserve variations and related optical coherence tomography findings: the FFR–OCT co-registration study

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

We sought to assess in-stent variations in fractional flow reserve (FFR) in patients with previous percutaneous coronary intervention (PCI) and to associate any drop in FFR with findings by optical coherence tomography (OCT) imaging. Suboptimal post-PCI FFR values were previously associated with poor outcomes. It is not known to which extent in-stent pressure loss contributes to reduced FFR. In this single-arm observational study, 26 patients who previously underwent PCI with drug-eluting stent or scaffold implantation were enrolled. Motorized FFR pullback during continuous intravenous adenosine infusion and OCT assessments was performed. Post-PCI FFR < 0.94 was defined as suboptimal. At a median of 63 days after PCI (interquartile range: 59–64 days), 18 out of 26 patients (72%) had suboptimal FFR. The in-stent drop in FFR was significantly higher in patients with suboptimal FFR vs. patients with optimal FFR (0.08 ± 0.07 vs. 0.01 ± 0.02, p < 0.001). Receiver operating characteristic curve analysis showed that an in-stent FFR variation of > 0.03 was associated with suboptimal FFR. In patients with suboptimal FFR, the OCT analyses revealed higher mean neointimal area (respectively: 1.06 ± 0.80 vs. 0.51 ± 0.23 mm2; p = 0.018) and higher neointimal thickness of covered struts (respectively 0.11 ± 0.07 vs. 0.06 ± 0.01 mm; p = 0.021). Suboptimal FFR values following stent-implantation are mainly caused by significant in-stent pressure loss during hyperemia. This finding is associated to a larger neointimal proliferation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Shaw LJ, Berman DS, Maron DJ et al (2008) Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117:1283–1291

    Article  PubMed  Google Scholar 

  2. Tonino PA, De Bruyne B, Pijls NH et al (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:213–224

    Article  CAS  PubMed  Google Scholar 

  3. De Bruyne B, Pijls NH, Kalesan B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991–1001

    Article  PubMed  Google Scholar 

  4. Bangalore S, Kumar S, Fusaro M et al (2012) Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation 125:2873–2891

    Article  CAS  PubMed  Google Scholar 

  5. Palmerini T, Biondi-Zoccai G, Della Riva D et al (2012) Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 379:1393–1402

    Article  CAS  PubMed  Google Scholar 

  6. Pijls NH, De Bruyne B, Peels K et al (1996) Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334:1703–1708

    Article  CAS  PubMed  Google Scholar 

  7. Pijls NH, Van Gelder B, Van der Voort P et al (1995) Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 92:3183–3193

    Article  CAS  PubMed  Google Scholar 

  8. Hanekamp CE, Koolen JJ, Pijls NH, Michels HR, Bonnier HJ (1999) Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment. Circulation 99:1015–1021

    Article  CAS  PubMed  Google Scholar 

  9. Foin N, Gutierrez-Chico JL, Nakatani S et al (2014) Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition. Circ Cardiovasc Interv 7:180–189

    Article  PubMed  Google Scholar 

  10. Matthys K, Carlier S, Segers P et al (2001) In vitro study of FFR, QCA, and IVUS for the assessment of optimal stent deployment. Cathet Cardiovasc Interv 54:363–375

    Article  CAS  Google Scholar 

  11. Pijls NH, Klauss V, Siebert U et al (2002) Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation 105:2950–2954

    Article  PubMed  Google Scholar 

  12. Johnson NP, Toth GG, Lai D et al (2014) Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol 64:1641–1654

    Article  PubMed  Google Scholar 

  13. Prati F, Regar E, Mintz GS et al (2010) Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 31:401–415

    Article  PubMed  Google Scholar 

  14. Rickham PP (1964) Human Experimentation. Code of Ethics of the World Medical Association. Declaration of Helsinki. Br Med J 2:177

    Article  CAS  PubMed  Google Scholar 

  15. Bartunek J, Sys SU, Heyndrickx GR, Pijls NH, De Bruyne B (1995) Quantitative coronary angiography in predicting functional significance of stenoses in an unselected patient cohort. J Am Coll Cardiol 26:328–334

    Article  CAS  PubMed  Google Scholar 

  16. Pyxaras SA, Tu S, Barbato E, Reiber JH, Wijns W (2013) Optimization of Tryton dedicated coronary bifurcation system with coregistration of optical coherence tomography and fractional flow reserve. JACC Cardiovasc Interv 6:e39-40

    Article  PubMed  Google Scholar 

  17. Pyxaras SA, Tu S, Barbato E, Wyffels E, Reiber JH, Wijns W (2013) Co-registration of fractional flow reserve and optical coherence tomography with the use of a three-dimensional angiographic roadmap: an opportunity for optimisation of complex percutaneous coronary interventions. EuroIntervention 9:889

    Article  PubMed  Google Scholar 

  18. Imola F, Mallus MT, Ramazzotti V et al (2010) Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. EuroIntervention 6:575–581

    Article  PubMed  Google Scholar 

  19. Tanigawa J, Barlis P, Di Mario C (2007) Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention 3:128–136

    PubMed  Google Scholar 

  20. Prati F, Romagnoli E, Burzotta F et al (2015) Clinical impact of OCT findings during PCI: the CLI-OPCI II study. JACC Cardiovasc Imaging 8:1297–1305

    Article  PubMed  Google Scholar 

  21. Tearney GJ, Regar E, Akasaka T et al (2012) Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 59:1058–1072

    Article  PubMed  Google Scholar 

  22. Finn AV, Joner M, Nakazawa G et al (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435–2441

    Article  PubMed  Google Scholar 

  23. Serruys PW, Onuma Y, Ormiston JA et al (2010) Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation 122:2301–2312

    Article  CAS  PubMed  Google Scholar 

  24. Rodes-Cabau J, Gutierrez M, Courtis J et al (2011) Importance of diffuse atherosclerosis in the functional evaluation of coronary stenosis in the proximal-mid segment of a coronary artery by myocardial fractional flow reserve measurements. Am J Cardiol 108:483–490

    Article  PubMed  Google Scholar 

  25. De Bruyne B, Hersbach F, Pijls NH et al (2001) Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but “Normal” coronary angiography. Circulation 104:2401–2406

    Article  PubMed  Google Scholar 

  26. Fearon WF, Luna J, Samady H et al (2001) Fractional flow reserve compared with intravascular ultrasound guidance for optimizing stent deployment. Circulation 104:1917–1922

    Article  CAS  PubMed  Google Scholar 

  27. Kawamori H, Shite J, Shinke T et al (2013) Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up. Eur Heart J Cardiovasc Imaging 14:865–875

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors of the study are grateful to Medis Medical Imaging Systems bv for supplying the specialized software used in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William Wijns.

Ethics declarations

Conflict of interest

Shengxian Tu received a research grant support from Medis Medical Imaging Systems bv. Johan H. C. Reiber is the CEO of Medis Medical Imaging Systems bv, and has a part-time appointment at LUMC as Professor of Medical Imaging. William Wijns is co-founder and non-executive board member of Argonauts. Stylianos Pyxaras has received consultancy fees from St. Jude Medical; he received an unrestricted educational EAPCI training grant from Medtronic in 2013. Cardiovascular Research Center Aalst has received institutional grants from various device companies, including St. Jude Medical, Terumo and Tryton Medical.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pyxaras, S.A., Adriaenssens, T., Barbato, E. et al. In-stent fractional flow reserve variations and related optical coherence tomography findings: the FFR–OCT co-registration study. Int J Cardiovasc Imaging 34, 495–502 (2018). https://doi.org/10.1007/s10554-017-1262-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-017-1262-4

Keywords

Navigation